Heplisav-B Vaccination Schedule: Managing Delayed Doses

Understanding Heplisav-B Dosing Schedule

• The Centers for Disease Control and Prevention recommends Heplisav-B as a 2-dose series with doses given at 0 and 1 month for adults aged ≥18 years 1

Management of Interrupted Vaccination Schedules

• The Advisory Committee on Immunization Practices (ACIP) states that when any hepatitis B vaccine schedule is interrupted, the series does not need to be restarted 1, 2, 3
• For interrupted schedules, the delayed dose should be administered as soon as possible 2, 3

Evidence-Based Rationale

• The ACIP guidelines state: "If the HepB vaccination schedule is interrupted, the series does not need to be restarted" 1
• This recommendation is based on the understanding that the immune system maintains memory of previous vaccine doses, even with extended intervals 2
• Administering the second dose later than scheduled still provides protection 3

Special Considerations

• For immunocompromised patients, completing the series as soon as possible is particularly important 4, 5

Common Pitfalls to Avoid

• The ACIP recommends not restarting the Heplisav-B series if the interval between doses exceeds 1 month 1, 2

Monitoring After Vaccination

• The Centers for Disease Control and Prevention recommends routine post-vaccination serologic testing for certain high-risk groups including healthcare personnel, hemodialysis patients, HIV-infected persons, and other immunocompromised individuals 3, 6
• Testing should be performed 1-2 months after the final dose to confirm seroprotection 6